Multiple myeloma research led by researchers at the University of Calgary identified how tumor cells adapt after ...

By Sneha S K April 13 (Reuters) - Allogene Therapeutics said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of cancer relapse ...

Mixed histiocytosis (Langerhans cell histiocytosis [LCH] / Erdheim-Chester disease [ECD]) developing after treatment for ...

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

Experts recommended individualized MDD relapse prevention, including ECT tapering and pharmacotherapy based on risk profiles.

April 13 (Reuters) - Allogene Therapeutics said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of cancer relapse in patients ...